Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CARIPRAZINE vs CASPOFUNGIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CARIPRAZINE vs CASPOFUNGIN: Safety Overview

Metric CARIPRAZINE CASPOFUNGIN
Total FAERS Reports 6,547 3,814
Deaths Reported 194 1,419
Death Rate 3.0% 37.2%
Hospitalizations 702 1,638
Average Patient Age 40.4 yrs 47.5 yrs
% Female Patients 64.0% 42.8%
FDA Approval Date Dec 16, 2025 Dec 30, 2016
Manufacturer Allergan, Inc. Sandoz Inc
Route ORAL INTRAVENOUS
Marketing Status Prescription Discontinued